These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 4970482

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Double-blind clinical trial of a new coronary-active drug, MD 6753].
    Dalla Volta S.
    Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lidoflazine: a new drug in the treatment of angina pectoris.
    Bernstein V, Peretz DI.
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):483-95. PubMed ID: 4404702
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Methods o clinical evaluation of therapeutic agents for the treatment of angina pectoris].
    Mabuchi G.
    Nihon Ika Daigaku Zasshi; 1970 Aug; 37(5):343-58. PubMed ID: 4923115
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The clinical effect of 4-(2'-nitrophenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine (BAY a 1040) on angina pectoris evaluated by sequential analysis.
    Kimura E, Mabuchi G, Kikuchi H.
    Arzneimittelforschung; 1972 Feb; 22(2):365-7. PubMed ID: 4623700
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of lidoflazine as an anti-anginal drug.
    Vohra JK, Sloman JG.
    Cardiology; 1973 Feb; 58(4):209-19. PubMed ID: 4206284
    [No Abstract] [Full Text] [Related]

  • 15. [Verapamil in the treatment of angina pectoris. Comparative double-blind study with fendilin].
    Albuquerque DC, Schlesinger P, Benchimol CB, Albanesi FM, Benchimol AB.
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():63-7. PubMed ID: 354613
    [No Abstract] [Full Text] [Related]

  • 16. [Importance of the placebo in the clinical evaluation of so-called coronary vasodilator agents in patients with clinical manifestations of angina pectoris].
    Calandre L, Ruano JM.
    Rev Esp Cardiol; 1965 Apr; 18(2):168-72. PubMed ID: 5319557
    [No Abstract] [Full Text] [Related]

  • 17. [Results of treatment of a coronary pain syndrome with lidoflazine].
    Dvorák I, Zemánková J, Soják K.
    Vnitr Lek; 1973 Oct; 19(10):943-8. PubMed ID: 4586010
    [No Abstract] [Full Text] [Related]

  • 18. [Long-term controlled clinical trial of a new anti-anginal drug].
    Belli C, Martinesi L.
    Clin Ter; 1971 Feb 15; 56(3):245-64. PubMed ID: 4996440
    [No Abstract] [Full Text] [Related]

  • 19. [The treatment of angina pectoris. 1].
    Baedeker W.
    Med Klin; 1970 Oct 23; 65(43):1893-6. PubMed ID: 4990934
    [No Abstract] [Full Text] [Related]

  • 20. [Lidoflazine in angina pectoris. I. Double blind study].
    Batlouni M, Betolami V, Duprat R.
    Arq Bras Cardiol; 1968 Oct 23; 21(5):321-6. PubMed ID: 4886984
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.